World's Best Scientists 2026 revealed!
Yusuke Oji

Yusuke Oji

D-Index & Metrics

Immunology

D-Index
53
Citations
11556
World Ranking
3965
National Ranking
155

Overview

Yusuke Oji is affiliated with Osaka University in Japan and has contributed extensively to the fields of medicine, immunology and microbiology, and biochemistry, genetics and molecular biology. Their research primarily spans immunology, molecular biology, and oncology, with additional work in radiology, nuclear medicine and imaging, and genetics.

The main research topics addressed by Yusuke Oji include renal and related cancers, immunotherapy and immune responses, CAR-T cell therapy research, cancer immunotherapy and biomarkers, immune cell function and interaction, epigenetics and DNA methylation, and T-cell and B-cell immunology.

Frequent publication venues for Yusuke Oji include:

  • Cancer Immunology Immunotherapy
  • Journal of Hematology & Oncology
  • Neuro-Oncology Advances
  • Science Translational Medicine
  • Journal of Immunotherapy

Yusuke Oji has collaborated extensively with several researchers, including:

  • Haruo Sugiyama
  • Yoshitaka Oka
  • Akihiro Tsuboi
  • Soyoko Morimoto
  • Hiroko Nakajima

Selected recent papers authored or co-authored by Yusuke Oji are:

  • Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain, 2022, Science Translational Medicine
  • Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer, 2021, Journal of Immunotherapy
  • Imaging Assessment of Tumor Response in the Era of Immunotherapy, 2021, Diagnostics
  • Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy, 2020, Biomedical Reports
  • Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy, 2021, Cancer Immunology Immunotherapy

Best Publications

  • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

    Yoshihiro Oka;Akihiro Tsuboi;Tetsuya Taguchi;Tadashi Osaki

  • CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

    Naoki Hosen;Christopher Y. Park;Naoya Tatsumi;Yusuke Oji

  • Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

    Kazushi Inoue;Hiroyasu Ogawa;Hiroyasu Ogawa;Yoshiaki Sonoda;Yoshiaki Sonoda;Takafumi Kimura;Takafumi Kimura

  • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

    Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

  • Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.

    Yoshihiro Oka;Olga A. Elisseeva;Akihiro Tsuboi;Hiroyasu Ogawa

  • Immunohistochemical detection of WT1 protein in a variety of cancer cells

    Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

  • The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.

    Hiroyasu Ogawa;Hiroya Tamaki;Kazuhiro Ikegame;Toshihiro Soma

  • Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

    Yusuke Oji;Shinichiro Miyoshi;Hajime Maeda;Seiji Hayashi

  • Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

    Kazushi Inoue;Hiroyasu Ogawa;Tamotsu Yamagami;Toshihiro Soma

  • Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

    Kazushi Inoue;Hiroya Tamaki;Hiroyasu Ogawa;Yoshihiro Oka

  • The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.

    H. Tamaki;H. Ogawa;K. Ohyashiki;Jh H. Ohyashiki

  • Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

    Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

  • Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies.

    Olga A. Elisseeva;Yoshihiro Oka;Akihiro Tsuboi;Kiyoyuki Ogata

  • Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.

    Yusuke Oji;Shoji Nakamori;Masahiro Fujikawa;Shin-ichi Nakatsuka

  • Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

    Naoki Hosen;Yoshiaki Sonoda;Yusuke Oji;Takafumi Kimura

  • Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors

    Yusuke Oji;Tsuyoshi Suzuki;Yoko Nakano;Motohiko Maruno

  • The activated conformation of integrin β 7 is a novel multiple myeloma–specific target for CAR T cell therapy

    Naoki Hosen;Yukiko Matsunaga;Kana Hasegawa;Hiroshi Matsuno

  • Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

    Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

  • Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma

    Yusuke Oji;Hirofumi Yamamoto;Masaya Nomura;Yoko Nakano

  • AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

    Sumiyuki Nishida;Naoki Hosen;Toshiaki Shirakata;Keisuke Kanato

  • Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

    Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

Frequent Co-Authors

Haruo Sugiyama
Haruo Sugiyama Osaka University
Yoshihiro Oka
Yoshihiro Oka Osaka University
Atsushi Kumanogoh
Atsushi Kumanogoh Osaka University
Katsuyuki Aozasa
Katsuyuki Aozasa Osaka University
Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Satoshi Morita
Satoshi Morita Kyoto University
Eiichi Morii
Eiichi Morii Osaka University
Masaki Yasukawa
Masaki Yasukawa Ehime University
Zwi N. Berneman
Zwi N. Berneman University of Antwerp
Hideki Yoshikawa
Hideki Yoshikawa Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare education pathways can offer diverse opportunities. Many students transition into roles that bridge clinical care and research, where understanding the immune system is crucial.

One popular option is an accelerated nurse practitioner program, which fast-tracks students into advanced nursing roles. These programs emphasize both clinical skills and scientific knowledge, complementing immunology expertise.

If you are coming from a non-nursing background, enrolling in the best online BSN programs for non nurses can provide foundational nursing knowledge alongside flexible learning formats suited to busy schedules.

When looking for accessible entry points into nursing, options such as the easiest ABSN programs to get into or accredited LPN programs easy to get into may serve as practical pathways. These programs prioritize inclusivity and often feature streamlined admissions processes.

Combining immunology studies with nursing credentials can open doors in clinical research, healthcare delivery, and public health, making these related degrees valuable complements to an immunology career.

Best Scientists Citing Yusuke Oji

Trending Scientists